Development Intelligence

Vision 60 CBRN Quadruped – Excellent Commercial Product Trial-Use: South Korea test and trial record

In May-26, Republic of Korea Ministry of National Defense / military services evaluated or demonstrated Vision 60 quadruped configured for CBRN operations under Vision 60 CBRN Quadruped – Excellent Commercial Product Trial-Use Evaluation, with Ghost Robotics / Korean programme integrator not fully disclosed linked to the activity.

By Avantika Kapoor, Chief Research Officer and Co-FounderPublished 2 min read
LinkedIn

Source-linked Intelligence Snapshot

UXVSEARCHER-3544

Original development / event date: May 2026

Programme
Vision 60 CBRN Quadruped – Excellent Commercial Product Trial-Use Evaluation
System / platform
Vision 60 quadruped configured for CBRN operations
Supplier
Ghost Robotics / Korean programme integrator not fully disclosed
Customer / operator
Republic of Korea Ministry of National Defense / military services
Geography
South Korea
Domain
UGV
Mission
CBRN reconnaissance; hazardous-area sensing; military trial-use evaluation
Activity
Product/Service Testing
Milestone stage
Validation / operational testing
Original value
Not disclosed · Not disclosed
USD qualification
Not disclosed
Quantity / scope
Trial-use candidate; exact quantity not disclosed
Production / shipment / delivery
Advanced into the 2026 military commercial-product evaluation / possible trial-use process
Contract period
Not applicable — Not applicable
Contract duration
Not applicable

Interpretation: technical maturity

Trial participation and travelled distance describe testing activity, not sales volumes.

Editorial responsibility: Tanish Prakash · Source review recorded 10 Oct 2026

Original references and evidence caveats

Original primary reference: https://www.kip.re.kr/src/uploads/20260424/2026%EB%85%84_%EC%9A%B0%EC%88%98%EC%83%81%EC%9A%A9%ED%92%88_%EC%8B%9C%EB%B2%94%EC%82%AC%EC%9A%A9_%EC%A0%9C%ED%92%88%EC%84%A4%EB%AA%85%ED%9A%8C_%EC%B6%94%EC%A7%84%EA%B3%84%ED%9A%8D%28%EA%B3%B5%EC%A7%80%EC%9A%A9%29.pdf

Original supporting reference: Not independently located

Pre-procurement trial-use candidate. Retained as a 2026 product-evaluation milestone, not a standard tender or signed purchase.

Reference notes are retained from the supplied source master. They do not establish independent verification of performance, deliveries, revenue or conversion.

Reported

Development and reported outcome

In May-26, Republic of Korea Ministry of National Defense / military services evaluated or demonstrated Vision 60 quadruped configured for CBRN operations under Vision 60 CBRN Quadruped – Excellent Commercial Product Trial-Use Evaluation, with Ghost Robotics / Korean programme integrator not fully disclosed linked to the activity.

Reporting limitation: The event remains a trial, exercise or demonstration rather than confirmed production demand.[S1]

Reported

Program, platform and stakeholders

Programme or contract: Vision 60 CBRN Quadruped – Excellent Commercial Product Trial-Use Evaluation. Platform or product: Vision 60 quadruped configured for CBRN operations. Recorded supplier, developer or relevant organization: Ghost Robotics / Korean programme integrator not fully disclosed (reported headquarters/country: United States / South Korea). Recorded customer, operator or intended user: Republic of Korea Ministry of National Defense / military services (reported headquarters/country: South Korea).[S1]

Reported

Mission and technical scope

The following are classifications recorded in the source master, not additional claims of operational deployment: Mission/use-case classification: CBRN reconnaissance; hazardous-area sensing; military trial-use evaluation. Mobility classification: Legged / Quadruped. Operating mode: Remote / Autonomous-capable.

Reported

Contract, value and shipment signals

Recorded quantity, delivery, demonstration or volume signal: Trial-use candidate; exact quantity not disclosed. Delivery schedule, procurement window or milestone status: Advanced into the 2026 military commercial-product evaluation / possible trial-use process.[S1]

Limitations

Source verification and interpretation limits

UXV Searcher master source-coverage note: Pre-procurement trial-use candidate. Retained as a 2026 product-evaluation milestone, not a standard tender or signed purchase.

Interpretation boundary: Testing, authorization and demonstrations should not be counted as confirmed purchases or fleet deliveries without a separate acceptance source.[S1]

UXV Searcher analysis

UXV Searcher analysis — what the development changes

UXV Searcher interpretation — validation / operational testing: The South Korea UGV record for Vision 60 CBRN Quadruped – Excellent Commercial Product Trial-Use Evaluation is best treated as a technical maturity signal. Testing, demonstration and certification-type activity can reduce integration uncertainty but is not equivalent to contracted fleet deployment.

Traceability for buyers: The dataset associates Ghost Robotics / Korean programme integrator not fully disclosed with Republic of Korea Ministry of National Defense / military services for Vision 60 quadruped configured for CBRN operations. This supports stakeholder mapping; supply-chain tier, exclusivity and signed-customer relationships need the underlying source before firm classification.

Client-use interpretation: For intelligence users tracking CBRN reconnaissance; hazardous-area sensing; military trial-use evaluation, the relevant next proof points are ground mobility, autonomy, payload integration and field acceptance. Monitor test result, qualification scope, operational acceptance and subsequent paid orders.[S1]

UXV Searcher analysis

Quantitative evidence, calculations and limits

Quantity/scope signal: Trial-use candidate; exact quantity not disclosed. Counting rule: Trial/deployment context; not necessarily procurement or paid fleet additions. Delivery/timing evidence: Advanced into the 2026 military commercial-product evaluation / possible trial-use process. Scheduling language is not independently proof of completion or acceptance.

Trial participation and travelled distance describe testing activity, not sales volumes.[S1]

Sources

Original reporting is credited to its publisher. The byline covers UXV Searcher's analysis only.

  1. [S1]Primary reference: kip.re.kr
    kip.re.kr
    Included in the provided master and its source notes; this export did not independently re-test the live URL or corroborate the claims.

Share this analysis

LinkedIn

Need the underlying records or a custom brief? Contact UXV Searcher or see access options.